http://www.zibb.com/all/theme/cq/Cell+Genesys+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Tue, 24 Nov 2009 15:53:00 GMTTue, 24 Nov 2009 15:53:00 GMT608831http://www.zibb.com/all/theme/cq/Cell+Genesys+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.cellgenesys.com/500 FORBES BOULEVARD SOUTH SAN FRANCISCO CALIFORNIA 94080 T 650.266.3000 F 650.266.http://www.cellgenesys.com/Cell Genesys Incorporatedhttp://www.hanechow.com/view.cfm/58/Cell-GenesysHane Chow Inc. 236 2nd Street, Oakland, CA 94607 / 510 302 0590 t / email: No Javascript! Studio / Work Work Annual Reports / Branding & Collateral / Packaging / Web Development Anza Therapeutics / Blue Bee Printing / Cell Genesys / CPI International / Depomed / Exelixis / Farmhouse Foods /http://www.hanechow.com/view.cfm/58/Cell-GenesysCell Genesys Incorporatedhttp://www.geron.com/partners/licensing/genesys.aspxWe initially granted a non-exclusive license to Genetic Therapy, Inc. (GTI), a subsidiary of Novartis AG, to use our telomerase promoter technology to develop an oncolytic virus product. Subsequently, GTI's oncolytic virus business including our license to GTI was acquired by Cell Genesys Inc.http://www.geron.com/partners/licensing/genesys.aspxCell Genesys Incorporatedhttp://www.maxygen.dk/about-leader.phpCorporate Leadership Russell J. Howard, Ph.D. Chief Executive Officer Dr. Howard has served as the Companyâ s Chief Executive Officer and as a director since June 1998. Dr. Howard was elected the Companyâ s President and Chief Operating Officer in May 1997.http://www.maxygen.dk/about-leader.phpCell Genesys Incorporatedhttp://www.biz-lib.com/ZEB67190.htmlOver 135 reports on companies developing anti-cancer drugs from the largest blue-chip multinational to smaller specialist organisations - and all phases of development from research to launched products.http://www.biz-lib.com/ZEB67190.htmlCell Genesys Incorporatedhttp://www.investorguide.com/stock-news.cgi?ticker=CEGETrack Any Stock Instantly Just enter up to ten of your stocks in the Stock Tracker box, click the ADD button beside any of Today's Hot Stocks, or click ADD beside any of the stocks you've Recently Viewed.http://www.investorguide.com/stock-news.cgi?ticker=CEGECell Genesys Incorporatedhttp://www.newratings.com/headlines/Cell-Genesys_US1509211041.htmlCopyright © 2002 - 2008 newratings.com GmbH | Legal | Licensing Quote data provided by IS.eFinance Solutions (powered by IS.Teledata AG) using StandardPoor's ComStock Inc. and others. Delay times are 15 mins for European exchanges and NASDAQ, 20 mins for NYSE and AMEX.http://www.newratings.com/headlines/Cell-Genesys_US1509211041.htmlCell Genesys Incorporatedhttp://www.evaluatepharma.com/CoInfo/CoInfo-CEGE.htmEvaluatePharma provides historic and forecast sales from 1986 to 2010 for worldwide and US Rx (prescription drugs) and OTC drugs. EvaluatePharma analysts continuously update company models from SEC filings, annual reports, investor/analyst presentations, company press releases, FDA and USPTO.http://www.evaluatepharma.com/CoInfo/CoInfo-CEGE.htmCell Genesys Incorporatedhttp://www.optomedia.co.uk/?q=Cell%20Genesys%20Informationoptomedia.co.uk search Cell Genesys Stock Genesys Water Chemotherapy Information Related Links Genesys Conferencing Cell Genesys Cell Genesys Stock Grand Blanc Mi Genesys Water CTI Inc Information on Pancreatic Cancer Genesis Master OTC Genesis Scan Chemotherapy Information Domain May Be For Salehttp://www.optomedia.co.uk/?q=Cell%20Genesys%20InformationCell Genesys Incorporatedhttp://www.xenova.co.uk/PressReleases/pr_20011002_01.htmlCAMBRIDGE, UK, 2nd October 2001 Phogen Limited today announced that it has entered into a research collaboration with Cell Genesys, Inc. (Nasdaq: CEGE) in the field of gene therapy, relating to the development of products for cancer and cardiovascular disease.http://www.xenova.co.uk/PressReleases/pr_20011002_01.htmlCell Genesys Incorporatedhttp://www.quotelinks.com/companies/cege.htmlStock quotes, news and charts for Cell Genesys, Inc. Quotes Simple Charts Stock News MSN Investor Thomson Investors Short Interest Yahoo Finance CBS Marketwatch BigCharts StockCharts.com Yahoo Lycos Investing Quicken Yahoo News Quote.com (Lycos) CNET news ZDNet Business Week Stock earnings,http://www.quotelinks.com/companies/cege.htmlCell Genesys Incorporatedhttp://www.californiabiotechlaw.com/archives/127130-print.htmlMarch 27th blog posting, entering into an alliance with a pharmaceutical company can still make good business sense, as in the case of the $320 million Cell Genesys-Takeda deal that closed this week.http://www.californiabiotechlaw.com/archives/127130-print.htmlCell Genesys Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=4194/PRNewswire-FirstCall/ -- Cell Genesys, Inc. (Nasdaq: CEGE) today reported additional results from its second multi-center Phase 2 trial of GVAX(R) vaccine for prostate cancer which evaluated escalating doses of the vaccine in 80 patients with advanced hormone- refractory metastatic prostate cancer.http://www.pharmacychoice.com/News/article.cfm?Article_ID=4194Cell Genesys Incorporatedhttp://www.medarex.com/cgi-local/item.pl/20060603-868189Cell Genesys and Medarex Announce Encouraging Interim Results from a Phase 1 Combination Therapy Trial With GVAX(R) Immunotherapy for Prostate Cancer and Ipilimumab (MDX-010) Antibodyhttp://www.medarex.com/cgi-local/item.pl/20060603-868189Cell Genesys Incorporatedhttp://www.fiercebiotech.com/story/cell-genesys-cuts-jobs-focuses-on-lead-drugs/2005-06-07FierceBiotech is the biotech industry daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and fda approval news.http://www.fiercebiotech.com/story/cell-genesys-cuts-jobs-focuses-on-lead-drugs/2005-06-07Cell Genesys Incorporatedhttp://www.thestreet.com/print/story/10443120.html(CEGE Quote - Cramer on CEGE - Stock Picks) is done. In the ashes of the biotech firm's blowup, however, there are important investing lessons to learn.http://www.thestreet.com/print/story/10443120.htmlCell Genesys Incorporatedhttp://www.thelabrat.com/jobs/companies/CellGenesys.shtmlCell Genesys is focused on the development and commercialization of gene therapies to treat major life-threatening diseases, including cancer and cardiovascular disease.http://www.thelabrat.com/jobs/companies/CellGenesys.shtmlCell Genesys Incorporatedhttp://stlouis.bizjournals.com/sanfrancisco/related_content.html?topic=Tularik%20Inc© 2008 American City Business Journals, Inc. and its licensors. All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of bizjournals.http://stlouis.bizjournals.com/sanfrancisco/related_content.html?topic=Tularik%20IncCell Genesys Incorporatedhttp://uk.finance.yahoo.com/q/h?s=CEGECopyright 2007 (c) Yahoo! UK Ltd. All rights reserved. Questions | Disclaimer | Quotes Information Quotes delayed except where indicated otherwise. Delay time is 20 mins for London stock exchange. See also delay times for other exchanges.http://uk.finance.yahoo.com/q/h?s=CEGECell Genesys Incorporatedhttp://www.siteselection.com/ssinsider/pwatch/pw020304.htmThe $840 retrofit of VW's plant in Sao Bernardo do Campo has triggered the facility's beginning production of the Polo compact (background photo), which the company is positioning in Brazil as its top-of-the-line compact.http://www.siteselection.com/ssinsider/pwatch/pw020304.htmCell Genesys Incorporatedhttp://www.biospace.com/news_story.aspx?StoryID=46840&full=1SOUTH SAN FRANCISCO, Calif., Feb. 22 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. , today announced that Stephen A. Sherwin, M.D., chairman and chief executive officer, and Sharon E.http://www.biospace.com/news_story.aspx?StoryID=46840&full=1Cell Genesys Incorporatedhttp://www.bio.org/events/2005/media/brunchbios.aspDonald L. Drakeman is the co-founder, President and CEO of Medarex, a Nasdaq-listed biotechnology company developing monoclonal antibodies for the treatment of life threatening and debilitating diseases.http://www.bio.org/events/2005/media/brunchbios.aspCell Genesys Incorporatedhttp://www.smartbrief.com/news/aanp/companyData.jsp?companyId=2556From Cell Genesys spring forth new gene therapies. The development-stage biotech focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform.http://www.smartbrief.com/news/aanp/companyData.jsp?companyId=2556Cell Genesys Incorporatedhttp://www.riskworld.com/pressrel/2001/01q2/PR01a069.htmFOSTER CITY, Calif., June 19 /PRNewswire/ -- Cell Genesys, today announced that in preclinical studies of hemophilia gene therapy, the delivery of the factor IX gene, a blood clotting gene, into the liver demonstrated clear treatment advantages compared to intramuscular injection.http://www.riskworld.com/pressrel/2001/01q2/PR01a069.htmCell Genesys Incorporatedhttp://www.newsrx.com/newsletters/Pharma-Business-Week/2007-03-12/3503122007288PB.htmlFor the fourth quarter of 2006, the company reported a net loss of $30.3 million, or $0.54 per fully diluted share, compared with net income of $19.1 million, or $0.33 per fully diluted share, for the same period in 2005.http://www.newsrx.com/newsletters/Pharma-Business-Week/2007-03-12/3503122007288PB.htmlCell Genesys Incorporated